AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10589887 — intervention group
Group type: COMPARATOR
Intervention: Thrice-weekly trimethoprim-sulfamethoxazole (160 mg/800 mg)
Number of subjects: 2625
Study 7852106 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily radiation therapy (RT) at 1.2 Gy BID (64.8 Gy, 72.0 Gy, 76.8 Gy, 81.6 Gy)
Number of subjects: 786
Study 7852106 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated hyperfractionated RT at 1.6 Gy BID (48.0 Gy, 54.4 Gy)
Number of subjects: 786
Study 7852106 — intervention group
Group type: EXPERIMENTAL
Intervention: 72.0 Gy arm
Number of subjects: 786
Study 7852106 — intervention group
Group type: COMPARATOR
Intervention: Age and Karnofsky Performance Scores (KPS)
Number of subjects: 786
Study 2045613 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (4 mg/ml) inhaled for 5 minutes
Number of subjects: 0
Study 2045613 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (0.4 mg/ml) inhaled for 5 minutes
Number of subjects: 0
Study 2045613 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline (250 mg) intravenous injection
Number of subjects: 0
Study 6173993 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlebotomy therapy
Number of subjects: 0
Study 6173993 — intervention group
Group type: COMPARATOR
Intervention: Low-dose chloroquine treatment
Number of subjects: 0
Study 31953634 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg pantoprazole per day for 3 months
Number of subjects: 60
Study 31953634 — intervention group
Group type: COMPARATOR
Intervention: No PPI therapy
Number of subjects: 60
Study 31538599 — intervention group
Group type: EXPERIMENTAL
Intervention: Suvorexant 10 mg
Number of subjects: 12
Study 31538599 — intervention group
Group type: EXPERIMENTAL
Intervention: Suvorexant 20 mg
Number of subjects: 12
Study 31538599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 29560910 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute stress
Number of subjects: 25
Study 29560910 — intervention group
Group type: COMPARATOR
Intervention: Control procedure
Number of subjects: 25
Study 27273347 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol-rich beverage
Number of subjects: 103
Study 27273347 — intervention group
Group type: COMPARATOR
Intervention: Beverage without polyphenols (Control)
Number of subjects: 103
Study 24106324 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory rib cage compression (ERCC)
Number of subjects: 20
Study 24106324 — intervention group
Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 20
Study 23767862 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg of herbal blend twice daily
Number of subjects: 100
Study 23767862 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 20730056 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk fortified with 2.4 g/day of prebiotic oligosaccharide and 1.9x10(7) c.f.u/day of probiotic Bifidobacterium lactis HN019
Number of subjects: 624
Study 20730056 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk fortified with prebiotic and probiotic
Number of subjects: 624
Study 20730056 — intervention group
Group type: COMPARATOR
Intervention: Control milk
Number of subjects: 624
Study 19123877 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage-myofascial induction
Number of subjects: 62
Study 19123877 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham ultrasound/magnetotherapy)
Number of subjects: 62
Study 16838539 — intervention group
Group type: EXPERIMENTAL
Intervention: Random-frequency two-tone complex
Number of subjects: 2
Study 16838539 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-frequency two-tone complex
Number of subjects: 2
Study 16838539 — intervention group
Group type: COMPARATOR
Intervention: Broadband noise
Number of subjects: 2
Study 12871456 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated elastic compression stockings (ECS) worn during treadmill exercise sessions
Number of subjects: 0
Study 12871456 — intervention group
Group type: COMPARATOR
Intervention: No graduated elastic compression stockings (no ECS) during treadmill exercise sessions
Number of subjects: 0
Study 10823430 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixation with a CSLP plate
Number of subjects: 46
Study 10823430 — intervention group
Group type: COMPARATOR
Intervention: No internal fixation
Number of subjects: 46
Study 10823430 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (plate and no plate)
Number of subjects: 46
Study 10823430 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with excellent or good results according to Odom's criteria
Number of subjects: 46
Study 10823430 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-retest procedure
Number of subjects: 46
Study 8895943 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 21
Study 8895943 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 21
Study 8895943 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 21
Study 8895943 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall patient cohort
Number of subjects: 21
Study 8895943 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonresponders
Number of subjects: 21
Study 8895943 — intervention group
Group type: EXPERIMENTAL
Intervention: Responders
Number of subjects: 21
Study 8341503 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraocular lens (IOL) implantation
Number of subjects: 26
Study 8341503 — intervention group
Group type: COMPARATOR
Intervention: No intraocular lens (IOL) implantation
Number of subjects: 26
Study 3786334 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg nasal nicotine solution (NNS)
Number of subjects: 0
Study 3786334 — intervention group
Group type: COMPARATOR
Intervention: 0.15 mg nasal nicotine solution (NNS)
Number of subjects: 0
Study 3786334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3786334 — intervention group
Group type: COMPARATOR
Intervention: 2.5 mg mecamylamine
Number of subjects: 0
Study 3786334 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated dosing with 2 mg NNS hourly for six hours
Number of subjects: 0
Study 29139314 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant factor VIIIFc (rFVIIIFc)
Number of subjects: 0
Study 29139314 — intervention group
Group type: COMPARATOR
Intervention: Pooled comparator (recombinant factor VIII products)
Number of subjects: 0
Study 27421287 — intervention group
Group type: EXPERIMENTAL
Intervention: Building Wealth and Health Network intervention (28-week duration)
Number of subjects: 103
Study 27421287 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial and full intervention groups
Number of subjects: 103
Study 27421287 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 103
Study 24249780 — intervention group
Group type: EXPERIMENTAL
Intervention: Aeroplane travel
Number of subjects: 77
Study 24251881 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 24
Study 24251881 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 24
Study 21987535 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren 150 mg/d for 7 days (aliskiren group, n = 10)
Number of subjects: 16
Study 21987535 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 6, no aliskiren)
Number of subjects: 16
Study 20539300 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 19
Study 20539300 — intervention group
Group type: EXPERIMENTAL
Intervention: Glipizide
Number of subjects: 19
Study 20539300 — intervention group
Group type: COMPARATOR
Intervention: Non-DM Control
Number of subjects: 19
Study 17136399 — intervention group
Group type: EXPERIMENTAL
Intervention: Lofexidine-naltrexone
Number of subjects: 18
Study 17136399 — intervention group
Group type: COMPARATOR
Intervention: Placebo-naltrexone
Number of subjects: 18
Study 16293536 — intervention group
Group type: EXPERIMENTAL
Intervention: Single concentration methacholine inhalation provocation test (SCIPT) with doses of 0.03-1.8 mg (maximal cumulated dose 3.6 mg)
Number of subjects: 22
Study 16293536 — intervention group
Group type: COMPARATOR
Intervention: Standard dosimeter method (SDM) with doses of 0.002-1.8 mg (maximal cumulative dose 3.5 mg)
Number of subjects: 22
Study 16293536 — intervention group
Group type: COMPARATOR
Intervention: Comparison of SCIPT and SDM
Number of subjects: 22
Study 12081202 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative radiotherapy
Number of subjects: 0
Study 12081202 — intervention group
Group type: COMPARATOR
Intervention: Short course radiotherapy
Number of subjects: 0
Study 9873842 — intervention group
Group type: EXPERIMENTAL
Intervention: Home treatment not available, less treatment in general
Number of subjects: 17
Study 9873842 — intervention group
Group type: COMPARATOR
Intervention: Matched cohort from Malmö centre
Number of subjects: 17
Study 8721461 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-coated circuits (HC group, n = 9)
Number of subjects: 18
Study 8721461 — intervention group
Group type: COMPARATOR
Intervention: Uncoated circuits (UC group, n = 9)
Number of subjects: 18
Study 8721461 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-coated circuits (HC group)
Number of subjects: 18
Study 8721461 — intervention group
Group type: COMPARATOR
Intervention: Uncoated circuits (UC group)
Number of subjects: 18
Study 1824527 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of diazepam
Number of subjects: 80
Study 1824527 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of nifedipine
Number of subjects: 80
Study 1824527 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of propranolol
Number of subjects: 80
Study 1824527 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of nifedipine and 40 mg of propranolol
Number of subjects: 80
Study 6339379 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral killed polyvalent bacterial vaccine (3 courses over 2 months, each course containing 10^10 Haemophilus influenzae and 7 x 10^9 Staphylococcus aureus organisms)
Number of subjects: 0
Study 6339379 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6339379 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral killed polyvalent bacterial vaccine
Number of subjects: 0
Study 30565181 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin hydrochloride oral solution (500 mg/5 mL)
Number of subjects: 24
Study 30565181 — intervention group
Group type: COMPARATOR
Intervention: Metformin hydrochloride tablets (500 mg)
Number of subjects: 24
Study 28629886 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and Self‐Compassion training program (2.5 hours/week for 8 weeks, 75% attendance, 45 minutes daily practice)
Number of subjects: 48
Study 26590993 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitative intervention with a DVD showing exercises focused on facial muscles (PD-group-A)
Number of subjects: 36
Study 26590993 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-guided facial rehabilitation with a proprioceptive/recognition approach (PD-group-B)
Number of subjects: 36
Study 26590993 — intervention group
Group type: COMPARATOR
Intervention: Control group (PD-Ctrl)
Number of subjects: 36
Study 24393594 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback-based Nintendo Wii training
Number of subjects: 58
Study 24393594 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintendo Wii Stillness test
Number of subjects: 58
Study 24393594 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintendo Wii Agility test
Number of subjects: 58
Study 24393594 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-of-day effect on COP variables
Number of subjects: 58
Study 22494145 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-centered intervention
Number of subjects: 713
Study 22494145 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive parenting (dimension of positive behavior support)
Number of subjects: 713
Study 18977579 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin 5IU bolus and placebo infusion
Number of subjects: 110
Study 18977579 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin 5IU bolus and oxytocin 30IU infusion
Number of subjects: 110
Study 18021388 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphadoxine-pyrimethamine (SP)
Number of subjects: 100
Study 18021388 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine (AQ)
Number of subjects: 100
Study 18021388 — intervention group
Group type: COMPARATOR
Intervention: Both SP and AQ
Number of subjects: 100
Study 18021388 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-GLURP-IgG antibodies
Number of subjects: 100
Study 18021388 — intervention group
Group type: COMPARATOR
Intervention: Other malaria antigens
Number of subjects: 100
Study 14727025 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 0
Study 14727025 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 11993625 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular carbohydrate‐electrolyte beverage (6.8% CHO, 18.7 mmol/L Na, 3.0 mmol/L K, 1,130 kJ/L)
Number of subjects: 24
Study 11993625 — intervention group
Group type: EXPERIMENTAL
Intervention: Low kilojoule electrolyte beverage (1% CHO, 18.7 mmol/L Na, 3.0 mmol/L K, 170 kJ/L)
Number of subjects: 24
Study 11993625 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 24
Study 9818609 — intervention group
Group type: EXPERIMENTAL
Intervention: B/Y visual field
Number of subjects: 61
Study 9818609 — intervention group
Group type: COMPARATOR
Intervention: W/W visual field
Number of subjects: 61
Study 9818609 — intervention group
Group type: EXPERIMENTAL
Intervention: B/Y perimetry
Number of subjects: 61
Study 9818609 — intervention group
Group type: EXPERIMENTAL
Intervention: RNFL assessment
Number of subjects: 61
Study 7663799 — intervention group
Group type: EXPERIMENTAL
Intervention: CP-99,994 (250 micrograms/2 hours)
Number of subjects: 14
Study 7663799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 1679668 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxatidine 150 mg nocte
Number of subjects: 232
Study 1679668 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 300 mg nocte
Number of subjects: 232
Study 6352883 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion
Number of subjects: 19
Study 6352883 — intervention group
Group type: COMPARATOR
Intervention: Intensive conventional therapy (three or four daily injections of insulin)
Number of subjects: 19
Study 31877773 — intervention group
Group type: EXPERIMENTAL
Intervention: High leptin/ghrelin ratio
Number of subjects: 72
Study 31877773 — intervention group
Group type: EXPERIMENTAL
Intervention: Low leptin/ghrelin ratio
Number of subjects: 72
Study 31877773 — intervention group
Group type: COMPARATOR
Intervention: Permissive underfeeding
Number of subjects: 72
Study 31877773 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptin/ghrelin ratio
Number of subjects: 72
Study 31877773 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and body mass index
Number of subjects: 72
Study 29572761 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly administration of paclitaxel and carboplatin (W‐TC)
Number of subjects: 38
Study 29572761 — intervention group
Group type: COMPARATOR
Intervention: 3 weeks of paclitaxel and carboplatin (TW‐TC)
Number of subjects: 38
Study 27456885 — intervention group
Group type: EXPERIMENTAL
Intervention: PLISSIT model based sexual counseling (4 weekly sessions, 90-120 min each)
Number of subjects: 88
Study 27456885 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 88
Study 24151926 — intervention group
Group type: COMPARATOR
Intervention: Incremental group (control) with composite resin (Tetric Ceram)
Number of subjects: 50
Study 24151926 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich technique using resin modified glass ionomer (Fuji II LC)
Number of subjects: 50
Study 24151926 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich technique using compomer (Compoglass F)
Number of subjects: 50
Study 24151926 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich technique using flowable composite resin (Tetric Flow)
Number of subjects: 50
Study 24151926 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich technique using self‐cure composite resin (Degufill SC)
Number of subjects: 50
Study 21878455 — intervention group
Group type: EXPERIMENTAL
Intervention: BG-12 240 mg three times daily
Number of subjects: 257
Study 21878455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257
Study 19129277 — intervention group
Group type: EXPERIMENTAL
Intervention: Confrontational counselling by a nurse with nortriptyline for smoking cessation
Number of subjects: 296
Study 19129277 — intervention group
Group type: COMPARATOR
Intervention: Regular counselling by a nurse with nortriptyline (control group 1)
Number of subjects: 296
Study 19129277 — intervention group
Group type: COMPARATOR
Intervention: Care as usual for smoking cessation by the general practitioner (control group 2)
Number of subjects: 296
Study 17684153 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 28
Study 17684153 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 28
Study 15861940 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited excision of the fistulous tract, wounds left opened for secondary intention healing.
Number of subjects: 83
Study 15861940 — intervention group
Group type: COMPARATOR
Intervention: Closed wound group (wide resection of skin and subcutaneous tissue, followed by primary closure).
Number of subjects: 83
Study 15861940 — intervention group
Group type: COMPARATOR
Intervention: Wide excision group (wide resection of skin and subcutaneous tissue, wounds left opened for secondary intention healing).
Number of subjects: 83
Study 12470294 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraglossal atropine
Number of subjects: 804
Study 12470294 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous anticholinergic
Number of subjects: 804
Study 12470294 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral and intradeltoid anticholinergics
Number of subjects: 804
Study 12470294 — intervention group
Group type: COMPARATOR
Intervention: Control group (no anticholinergic)
Number of subjects: 804
Study 9583064 — intervention group
Group type: EXPERIMENTAL
Intervention: Attractive female therapist
Number of subjects: 241
Study 9583064 — intervention group
Group type: COMPARATOR
Intervention: Less attractive female therapist
Number of subjects: 241
Study 9583064 — intervention group
Group type: EXPERIMENTAL
Intervention: Benign (communication) problem
Number of subjects: 241
Study 9583064 — intervention group
Group type: COMPARATOR
Intervention: Potentially embarrassing (sexual) problem
Number of subjects: 241
Study 8620668 — intervention group
Group type: EXPERIMENTAL
Intervention: Zileuton 600mg every 6 hours (q6h regimen)
Number of subjects: 12
Study 8620668 — intervention group
Group type: EXPERIMENTAL
Intervention: Zileuton 600mg every 8 hours (q8h regimen)
Number of subjects: 12
Study 2586434 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunochemotherapy (IM-C) group
Number of subjects: 305
Study 2586434 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (control) group
Number of subjects: 305
Study 2586434 — intervention group
Group type: EXPERIMENTAL
Intervention: OK-432 therapy
Number of subjects: 305
Study 2586434 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional infusion of LAK cells
Number of subjects: 305
Study 1084659 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate
Number of subjects: 6
Study 1084659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31282954 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 484
Study 31282954 — intervention group
Group type: EXPERIMENTAL
Intervention: 224 mg of edonerpic maleate
Number of subjects: 484
Study 31282954 — intervention group
Group type: EXPERIMENTAL
Intervention: 448 mg of edonerpic maleate
Number of subjects: 484
Study 28129772 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron polymaltose (IPM) 6 mg elemental iron/kg/day for 8 weeks
Number of subjects: 591
Study 28129772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 591
Study 28129772 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron polymaltose (IPM) in iron-replete children (serum ferritin ≥30 µg/l)
Number of subjects: 591
Study 28129772 — intervention group
Group type: COMPARATOR
Intervention: Placebo in iron-replete children (serum ferritin ≥30 µg/l)
Number of subjects: 591
Study 25399822 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea therapy
Number of subjects: 40
Study 25399822 — intervention group
Group type: COMPARATOR
Intervention: Normal TCD measurements (Control group)
Number of subjects: 40
Study 23451258 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Training (MT) alone
Number of subjects: 82
Study 23451258 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Theta Burst Stimulation (iTBS) alone
Number of subjects: 82
Study 23451258 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Training (MT) + Intermittent Theta Burst Stimulation (iTBS)
Number of subjects: 82
Study 21730007 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated systolic hypertension (ISH)
Number of subjects: 39260
Study 21730007 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined systolic-diastolic hypertension (SDH)
Number of subjects: 39260
Study 21730007 — intervention group
Group type: EXPERIMENTAL
Intervention: Reported systolic blood pressure (SBP)
Number of subjects: 39260
Study 21730007 — intervention group
Group type: EXPERIMENTAL
Intervention: Reported diastolic blood pressure (DBP)
Number of subjects: 39260
Study 21730007 — intervention group
Group type: COMPARATOR
Intervention: Women without reported hypertension
Number of subjects: 39260
Study 19191893 — intervention group
Group type: EXPERIMENTAL
Intervention: PACl14 (14 days)
Number of subjects: 592
Study 19191893 — intervention group
Group type: EXPERIMENTAL
Intervention: PAM14 (14 days)
Number of subjects: 592
Study 19191893 — intervention group
Group type: EXPERIMENTAL
Intervention: PACl10 (10 days)
Number of subjects: 592
Study 19191893 — intervention group
Group type: COMPARATOR
Intervention: PAM10 (10 days)
Number of subjects: 592
Study 19191893 — intervention group
Group type: COMPARATOR
Intervention: PACl7 (7 days)
Number of subjects: 592